|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.246 EUR | -0.27% |
|
-3.32% | -35.99% |
| 09/12 | Sources: Novo Nordisk Group Holding reduces stake in Evotec | DP |
| 09/12 | Evotec secondary ABB priced at EUR 5.10 per share, bookrunner says | RE |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 5 | ||||||||
| 22 | ||||||||
| 20 | ||||||||
| 25 | ||||||||
| 22 | ||||||||
| 12 | ||||||||
| 20 | ||||||||
| 16 | ||||||||
| 15 | ||||||||
| 22 | ||||||||
| 12 | ||||||||
| 14 | ||||||||
| 14 | ||||||||
| 4 | ||||||||
| 15 | ||||||||
| 12 | ||||||||
| - | - | |||||||
| 21 | ||||||||
| 12 | ||||||||
| Average | 16 | |||||||
| Weighted average by Cap. | 18 |
- Stock Market
- Equities
- EVT Stock
- Sector Evotec SE
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















